A Comparison of Open Radical Nephrectomy Complication Rates in Patients Treated with Neoadjuvant Sunitinib for Metastatic Renal Cell Carcinoma versus Non-Metastatic Renal Cell Carcinoma

Hussain, M.; Nair, Rajesh; Shaw, Greg L.; Powles, T.; Peters, John

doi:10.1016/j.bjmsu.2010.09.005

Search citation statements

Order By: Relevance

Paper Sections

Select...

Advanced Rcc1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2012

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…At the EAU Congress in Vienna, Hussain et al [ 33 ] from London presented a retrospective analysis comparing perioperative morbidity of 28 nonmetastatic with that of 22 metastatic RCC patients after preoperative sunitinib therapy. The authors concluded that surgery is technically more complex and difficult after upfront sunitinib therapy: the sunitinib-pretreated group had a significantly higher median blood loss (775 ml versus 320 ml), a longer operating time (195 min versus 128 min), and a higher number of intraoperative complications (5 versus 2).…”

Section: Advanced Rccmentioning

confidence: 99%

Renal Cell Carcinoma Update: News from the AUA, EAU, and ASCO Annual Meetings 2011

Schrader

Steffens

2012

ISRN Urology

View full text Add to dashboard Cite

Renal cell carcinoma (RCC) is one of the most important urologic malignancies with a continuously growing incidence and health economic relevance. In 2011, several hundred articles, abstracts, and lectures have been presented at the leading global urooncologic congresses. This review was composed to give an overview on the flood of novel findings dealing with diagnostics and therapy of both localized and advanced RCC. The most clinically relevant data are discussed in detail.

show abstract

Section: Advanced Rccmentioning

confidence: 99%